RNS Number : 1787Z
Superdry PLC
29 August 2018
SuperdryPlc
("Superdry" or "the Company")
29 August 2018
Notification and public disclosure of transactions by Director/persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")
On 29 August 2018, the Company was notified by Chris Lacey, Digital Director, that he had sold 4,279 ordinary shares of 5 pence each ("Ordinary Shares") in the Company.
This announcement, including the notification(s) below, is made in accordance with the requirements of the EU Market Abuse Regulation.
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Chris Lacey | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Digital Director/PDMR
| ||||
b)
| Initial notification /Amendment
| Initial Notification
| ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Superdry Plc | ||||
b)
| LEI
| 213800GAQMT2WL7BW361 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 5 pence each
ISIN: GB00B60BD277
| ||||
b)
| Nature of the transaction
| Sale of 4,279 Ordinary Shares by Chris Lacey. | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
|
| ||||
e)
| Date of the transaction
| 24 August 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) | ||||
For further information:
| |
Superdry Plc | |
Simon Callander Group General Counsel and Company Secretary | 44 (0) 1242 586643 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.